Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25329824 | 0.87 | FPR2 (0.33) | — | |
| SCHEMBL25911067 | 0.87 | FPR2 (0.33) | — | |
| SCHEMBL25910986 | 0.85 | PSEN1 (0.39) | — | |
| SCHEMBL25911078 | 0.85 | PSEN1 (0.39) | — | |
| SCHEMBL30492181 | 0.85 | PSEN1 (0.39) | — | |
| SCHEMBL25924555 | 0.82 | MAPT (0.35) | CAPN1MEN1MAPTKMT2A | |
| SCHEMBL25329624 | 0.79 | — | — | |
| SCHEMBL25911105 | 0.76 | USP30 (0.40) | AKR1B1MAPT | |
| SCHEMBL30492183 | 0.76 | USP30 (0.40) | AKR1B1MAPT | |
| SCHEMBL25911089 | 0.76 | USP30 (0.40) | AKR1B1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219511-A1 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | Heron Neutron Medical Corp. (TW) | 2023-08-02 | — | — | EP | disclosed |
| US-20230234973-A1 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | HERON NEUTRON MEDICAL CORP. (TW) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234973-A1 | INTERMEDIATE, PREPARING METHOD THEREOF, AND METHOD OF PREPARING DRUG | CYP2F1, SULT1A1, CYP4F3 | CAPN1 4799/4885AKR1B1 623/4885MEN1 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.